The availability of references and the sponsorship of original research cited in pharmaceutical advertisements

Cooper, Richelle J.; Schriger, David L.
February 2005
CMAJ: Canadian Medical Association Journal;2/15/2005, Vol. 172 Issue 4, p487
Academic Journal
Background: The primary goal of pharmaceutical advertisements is to convince physicians to prescribe the manufacturer's product. We sought to determine what materials are cited in support of claims in pharmaceutical ads and medical research articles, and whether health care professionals seeking to verify the claims could obtain these references. Methods: We reviewed 438 unique ads from the 1999 issues of 10 American medical journals, and a random sample of 400 references in medical research articles selected from the same journals. We classified references as journal article, data on file, meeting abstract or presentation, book or monograph, marketing report, prescribing information, government document or Internet site. We attempted to confirm or obtain each reference through library and Internet searches or by direct request from the manufacturer. The main outcome we sought to determine was the availability of the reference to a clinician. We also ascertained the source of funding for original research cited in the ads and the research articles. Results: In the 438 ads with medical claims, 126 contained no references and 312 contained 721 unique references. Of these ad references, 55% (396/721) cited journal articles and 19% (135/721) cited data on file. In contrast, in the sample of research article references, 88% (351/400) cited journal articles and 8% (33/400) cited books. Overall, 84% of the citations from the ads were available: 98% of journal articles, 86% of books, 71% of meeting abstracts or presentations and 20% of data-on-file references. In all, 99% of the sample of research article references were available. We determined that 58% of the original research cited in the pharmaceutical ads was sponsored by or had an author affiliated with the product's manufacturer, as compared with 8% of the articles cited in the research articles. Interpretation: Many pharmaceutical ads contain no references for medical claims. Although references to journal art...


Related Articles

  • Trends in Prescribing in Primary Care in Croatia, 2000–2012: Prescribing Volume, Costs and Regulatory Measures. Vojvodić, Željko; Nelken-Bestvina, Darja; Kurc-Bionda, Alma; Štimac, Danijela // Collegium Antropologicum;2014 Supplement, Vol. 38, p67 

    The rise of pharmaceutical costs is a significant burden to overall health care expenditure. The Croatian Health Insurance Fund (CHIF) in attempts of its containment, use administrative measures directed toward the two greatest generators: pharmaceutical industry, through negotiating prices and...

  • Prescribed opinions. Aldhous, Peter // New Scientist;1/6/2007, Vol. 193 Issue 2585, p17 

    The article focuses on the views of the author on the trustworthiness of the information on health and medicine provided by mass media. The sheer volume of publicity material emanating from drug firms leads to a preponderance of reports on the benefits of new drugs at the expense of articles...

  • FDA Defends Drug Review Proces Despite Criticisms From HRG.  // Chemical Market Reporter;04/05/99, Vol. 255 Issue 14, p17 

    Reports the decline in the rate of withdrawal of drugs in the United States (US). Reaction of the Public Citizen's Health Research Group concerning the US Food and Drug Administration's drug approval process; Concerns that caused the withdrawal of Redux, Posicor and Duract drugs in the market;...

  • Spectrum Pharmaceuticals to Present at the Citi Investment Research 2011 Global Health Care Investor Conference.  // Biomedical Market Newsletter;3/14/2011, p190 

    The article announces the participation of Spectrum Pharmaceuticals, a biotech firm, at the Citi Investment Research 2011 Global Health Care Investor Conference in New York City on March 2, 2011. Spectrum Pharmaceuticals is an integrated commercial and drug development operations with a primary...

  • A New Trade Framework for Global Healthcare R&D. Hubbard, Tim; Love, James // PLoS Biology;Feb2004, Vol. 2 Issue 2, p0147 

    Deals with a trade framework for global healthcare research and development. Growth of dissatisfaction with drug prices in the developed and developing world; Factors that lead to high drug prices; Details of the implementation of the Trade Related Aspects of Intellectual Property Rights...

  • Meeting Coverage. CER reviews valuable, but not used to full potential. Kaufman, Michele B. // Formulary;Jul2011, Vol. 46 Issue 7, p286 

    The article reports on research on comparative effectiveness reviews of drugs which was discussed at the Academy of Managed Care Pharmacy's 23rd Annual Meeting and Showcase in Minneapolis, Minnesota. The research suggested that the reviews are valuable resources for guiding medication use...

  • Questions and answers. Atienza, Audie // Journal of Health Services Research & Policy;Jan2004, Vol. 9 Issue 1, p61 

    The article presents question and answers related to health care services research and policy. One person asks about the context of health intervention and its importance. Another person questions about the impact of direct-to-consumer prescription drug advertising on the general public. A...

  • The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space. Stremersch, Stefan; Landsman, Vardit; Venkataraman, Sriram // Marketing Science;Jan/Feb2013, Vol. 32 Issue 1, p89 

    Patients increasingly request their physicians to prescribe specific brands of pharmaceutical drugs. A popular belief is that requests are triggered by direct-to-consumer advertising (DTCA). We examine the relationship between DTCA, patient requests, and prescriptions for statins. We find that...

  • Education in radiopharmacy and radiopharmaceutical chemistry: recent developments. Mather, S.J.; Westera, G. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 3, pBP48 

    Provides updates on education in radiopharmacy and radiopharmaceuticals chemistry as of March 2001. Establishment of a postgraduate diploma in Radiopharmaceutical Chemistry/Radiopharmacy by the Centre for Radiopharamceutical Science; Information on the International Radiopharmaceutical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics